Estrogen Patch Shortage: Causes, Alternatives, and How Long It May Last

The demand for estrogen patches has far outstripped supply, leaving women across the U.S. struggling to fill prescriptions. Major manufacturers are operating at full capacity, yet the shortage—expected to last up to three years—remains unresolved, according to Reuters.

Estrogen patches are a widely used form of hormone replacement therapy (HRT) for managing menopausal symptoms, alongside alternatives like gels, sprays, and oral tablets. The scarcity has forced many women to switch brands, adjust dosages, or go without treatment altogether.

With more than 1 million U.S. women entering menopause each year, per the National Institutes of Health (NIH), the impact of this shortage could be significant. Below, we explore the root causes, the benefits of estrogen patches, and viable alternatives.

Why Are Estrogen Patches in Short Supply?

The current shortage stems from a combination of factors, including:

• Surging demand: Prescriptions for estrogen-based HRT have tripled since 2018, with patch use increasing by over 200% in that period, according to health data company Truveta.
• Demographic shifts: Prescribing rates for women aged 45–54 rose 184%, and by February 2026, roughly 1 in 20 women in this age group had an estrogen-based HRT prescription.
• FDA labeling changes: In November 2025, the Food and Drug Administration (FDA) removed long-standing black box warnings from certain HRT products. These warnings, in place since 2002 following the Women’s Health Initiative study, had raised concerns about cardiovascular and cancer risks.
• Overstated risks: The FDA concluded that the warnings exaggerated risks for many women, particularly those starting therapy near menopause onset.

  “We removed the black box warnings on hormone replacement therapy to tell women the truth about the short-term and profound long-term public health benefits of hormone replacement therapy.”
  — FDA Commissioner Marty Makary, MD

G. Thomas Ruiz, MD, an OB-GYN at MemorialCare Orange Coast Medical Center in Fountain Valley, CA, noted the immediate impact of the FDA’s decision:

“As soon as the FDA changed its black box warning… I got so many patients who are no longer fearful.”

How Long Will the Shortage Last?

Federal health officials, including the U.S. Department of Health and Human Services (HHS), have confirmed that all five patch manufacturers are operating at full capacity. However, supply continues to fall short of demand, and the shortage is projected to persist for up to three years.

While the HHS has not declared an official national shortage, the situation remains critical for women relying on estrogen patches for symptom relief.

Alternatives to Estrogen Patches

Women unable to obtain estrogen patches have several effective alternatives, all of which treat menopausal symptoms without contributing to the supply crunch:

• Estrogen gels: Applied to the skin, these provide consistent hormone delivery.
• Estrogen sprays: A convenient option for those who prefer non-patch applications.
• Oral tablets: A widely available and familiar form of HRT.
• Vaginal estrogen: Targets localized symptoms with minimal systemic absorption.
• Non-hormonal options: For women who cannot or prefer not to use estrogen, alternatives like SSRIs, SNRIs, or gabapentin may help manage symptoms.

Consulting a healthcare provider is essential to determine the best alternative based on individual needs and medical history.